Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Molecular Partners AG Sponsored ADR (MOLN) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-18.66M |
|
$13.26M |
|
$-13.26M |
|
$17.96M |
|
$-17.96M |
|
$-0.70M |
|
$-18.66M |
|
$-18.66M |
|
$-18.66M |
|
$-18.66M |
|
$-18.66M |
|
$-18.66M |
|
$-17.96M |
|
$-17.34M |
|
37.27M |
|
37.27M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$152.35M |
|
$4.58M |
|
$4.61M |
|
$156.96M |
|
$9.97M |
|
-- |
|
$4.38M |
|
$14.35M |
|
$144.78M |
|
$142.58M |
|
$142.60M |
|
36.88M |
|
| Cash Flow Statement Financials | |
$-19.00M |
|
$38.89M |
|
$-0.34M |
|
$71.05M |
|
$90.52M |
|
$19.46M |
|
$1.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.28 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.88% |
|
-13.08% |
|
-11.89% |
|
-13.08% |
|
$3.87 |
|
$-0.52 |
|
$-0.51 |
|